In:
The Oncologist, Oxford University Press (OUP), Vol. 12, No. 3 ( 2007-03-01), p. 312-319
Kurzfassung:
After completing this course, the reader will be able to: Identify the clinical features of oxaliplatin-induced neuropathy.Discuss the current approaches for managing chemotherapy-induced neuropathy.Explain the rationale for using glutamine in preventing oxaliplatin-induced neuropathy. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
Materialart:
Online-Ressource
ISSN:
1083-7159
,
1549-490X
DOI:
10.1634/theoncologist.12-3-312
Sprache:
Englisch
Verlag:
Oxford University Press (OUP)
Publikationsdatum:
2007
ZDB Id:
2023829-0
Permalink